Because the PI3K signaling pathway is one of the most commonly activated and dysregulated pathways in cancers and many of the kinases in this pathway are dependent on HSP90 for its stabilization33, the inhibition of HSP90 could be an effective therapy. This evidence concerns the gene HSP90AA1 and cancer.